Protagenic Stock Analysis

PTIX -  USA Stock  

USD 2.99  0.12  3.86%

The current slide in stock price may encourage investors to take a closer look at the company as it is trading at a share price of 2.99 on 1,605,299 in trading volume. The company directors and management have failed to build on market volatilities in May. However, diversifying your overall positions with Protagenic Therapeutics may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 11.67. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Protagenic Therapeutics partners.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Protagenic Therapeutics stock analysis report makes it easy to digest most publicly released information about Protagenic Therapeutics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Protagenic stock analysis module also helps to analyze the Protagenic Therapeutics price relationship with some important fundamental indicators such as market cap and management efficiency.

Protagenic Stock Analysis Notes

About 22.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.25. Protagenic Therapeutics had not issued any dividends in recent years. The entity had 3:2 split on the 27th of July 2016. Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company was founded in 2016 and is based in New York, New York. Protagenic Therapeutics operates under Networking Communication Devices classification in the United States and is traded on NASDAQ Exchange. To find out more about Protagenic Therapeutics contact the company at 212 994 8200 or learn more at http://www.protagenic.com.

Protagenic Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Protagenic Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Protagenic Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Protagenic Therapeutics generates negative expected return over the last 90 days
Protagenic Therapeutics has high historical volatility and very poor performance
The company reported the previous year's revenue of 25.95 M. Net Loss for the year was (2.55 M) with profit before overhead, payroll, taxes, and interest of 0.
Protagenic Therapeutics currently holds about 671.09 K in cash with (1.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Roughly 22.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.benzinga.com: 46 Stocks Moving In Fridays Mid-Day Session - Benzinga

Protagenic Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 31.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Protagenic Therapeutics's market, we take the total number of its shares issued and multiply it by Protagenic Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (185.27) % which means that it has lost $185.27 on every $100 spent on asset. This is way below average. Protagenic Therapeutics management efficiency ratios could be used to measure how well protagenic therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Protagenic Therapeutics holds the risk adjusted performance of (0.008402), and Coefficient Of Variation of (3,502). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protagenic Therapeutics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Protagenic Therapeutics, which can be compared to its competitors. Please check Protagenic Therapeutics variance and potential upside to decide if Protagenic Therapeutics is priced some-what accurately, providing market reflects its current price of 2.99 per share. Please also confirm Protagenic Therapeutics total risk alpha, which is currently at (1.44) to check out the company can sustain itself at a future point.

Protagenic Therapeutics Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Protagenic Therapeutics more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Protagenic Therapeutics Predictive Daily Indicators

Protagenic Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Protagenic Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Protagenic Therapeutics Forecast Models

Protagenic Therapeutics time-series forecasting models is one of many Protagenic Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Protagenic Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Protagenic Therapeutics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Protagenic Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Protagenic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Protagenic Therapeutics. By using and applying Protagenic Stock analysis, traders can create a robust methodology for identifying Protagenic entry and exit points for their positions.
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company was founded in 2016 and is based in New York, New York. Protagenic Therapeutics operates under Networking Communication Devices classification in the United States and is traded on NASDAQ Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Protagenic Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module
Please check Your Equity Center. Note that the Protagenic Therapeutics information on this page should be used as a complementary analysis to other Protagenic Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Protagenic Therapeutics Stock analysis

When running Protagenic Therapeutics stock analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' stock examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
The market value of Protagenic Therapeutics is measured differently than its book value, which is the value of Protagenic that is recorded on the company's balance sheet. Investors also form their own opinion of Protagenic Therapeutics stock's value that differs from its market value or its book value, called intrinsic value, which is Protagenic Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagenic Therapeutics' market value can be influenced by many factors that don't directly affect Protagenic Therapeutics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagenic Therapeutics' stock value and its price as these two are different measures arrived at by different means. Investors typically determine Protagenic Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagenic Therapeutics' stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.